Alpha-galactosidase A (GLA / α-Gal A) drugs for Fabry Disease
4 tracked Alpha-galactosidase A (GLA / α-Gal A) drugs in the Fabry Disease race. The class explanation lives on the Alpha-galactosidase A (GLA / α-Gal A) page; the full indication pipeline across every mechanism is on the Fabry Disease page.
3 approved / phase 41 Phase 1/2
Head-to-head evidence: Agalsidase beta vs Migalastat · Agalsidase beta vs isaralgagene civaparvovec · Agalsidase beta vs pegunigalsidase alfa · isaralgagene civaparvovec vs Migalastat · Migalastat vs pegunigalsidase alfa · isaralgagene civaparvovec vs pegunigalsidase alfa